Pathogenic variants inTNRC6Bcause a genetic disorder characterised by developmental delay/intellectual disability and a spectrum of neurobehavioural phenotypes including autism and ADHD

J.L. Granadillo, A.P.A. Stegmann, H. Guo, K. Xia, B. Angle, K. Bontempo, J.D. Ranells, P. Newkirk, C. Costin, J. Viront, C.T. Stumpel, M. Sinnema, B. Panis, R. Pfundt, I.P.C. Krapels, M. Klaassens, J. Nicolai, J.L. Li, Y.W. Jiang, E. MarcoA. Canton, A.C. Latronico, L. Montenegro, B. Leheup, C. Bonnet, S.M. Amudhavalli, C.E. Lawson, K. McWalter, A. Telegrafi, R. Pearson, M. Kvarnung, X. Wang, W.M. Bi, J.A. Rosenfeld, M. Shinawi*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Web of Science)

Abstract

Background Rare variants in hundreds of genes have been implicated in developmental delay (DD), intellectual disability (ID) and neurobehavioural phenotypes.TNRC6Bencodes a protein important for RNA silencing. Heterozygous truncating variants have been reported in three patients from large cohorts with autism, but no full phenotypic characterisation was described. Methods Clinical and molecular characterisation was performed on 17 patients withTNRC6Bvariants. Clinical data were obtained by retrospective chart review, parent interviews, direct patient interaction with providers and formal neuropsychological evaluation. Results Clinical findings included DD/ID (17/17) (speech delay in 94% (16/17), fine motor delay in 82% (14/17) and gross motor delay in 71% (12/17) of subjects), autism or autistic traits (13/17), attention deficit and hyperactivity disorder (ADHD) (11/17), other behavioural problems (7/17) and musculoskeletal findings (12/17). Other congenital malformations or clinical findings were occasionally documented. The majority of patients exhibited some dysmorphic features but no recognisable gestalt was identified. 17 heterozygousTNRC6Bvariants were identified in 12 male and five female unrelated subjects by exome sequencing (14), a targeted panel (2) and a chromosomal microarray (1). The variants were nonsense (7), frameshift (5), splice site (2), intragenic deletions (2) and missense (1). Conclusions Variants inTNRC6Bcause a novel genetic disorder characterised by recurrent neurocognitive and behavioural phenotypes featuring DD/ID, autism, ADHD and other behavioural abnormalities. Our data highly suggest that haploinsufficiency is the most likely pathogenic mechanism.TNRC6Bshould be added to the growing list of genes of the RNA-induced silencing complex associated with ID/DD, autism and ADHD.
Original languageEnglish
Pages (from-to)717-724
Number of pages8
JournalJournal of Medical Genetics
Volume57
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Keywords

  • adhd
  • argonaute
  • autism
  • autosomal dominant
  • de novo
  • de-novo
  • developmental delay
  • growth
  • intellectual disability
  • mutations
  • ADHD
  • DE-NOVO
  • ARGONAUTE
  • De novo
  • INTELLECTUAL DISABILITY
  • GROWTH
  • MUTATIONS

Cite this